Cell and Life Therapeutics announces that Prof.Ankur Jain in MIT Biology Dept., joins the Company as CSO and the opening of its US company.
Cell and Life Therapeutics is developing next-generation small-molecule medicines to target the RNA cycle for treating neurodegenerative and oncology disorders. In collaboration with Jubilant Biosys, Cell and Life Therapeutic has established “STAR (Small-molecule TArgeting RNA biology)” library platform. Recently Cell and Life Therapeutic has selected a preclinical candidate for muscle atrophy diseases and potentially immune-oncology modulators. Cell […]
EmstoPA has received the Regulatory Endorsement of Development Program by British MHRA
We are proud to announce that our client EmstoPA has received the Regulatory Endorsement of Development Program by British MHRA and US FDA: The Medicines & Healthcare Products Regulatory Agency have recently reviewed and endorsed EmstoPA’s Plan, providing excellent feedback on each aspect. FDA has also reviewed and provided positive feedback for EmstoPA development plan EmstoPA has […]
